Health Care/Hospital

Heartstream Launched as Independent Emergency Care Company

Former Philips Emergency Care business becomes first platform company of Emergency Care Holdings, advancing a century-long mission to save lives BOTHELL, Wash., Jan. 15, 2026 /PRNewswire/ -- Emergency Care Holdings (ECH), a platform formed by Bridgefield Capital to assemble and grow category-lead...

2026-01-15 00:45 2471

Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Yuyu Bio and Mervyn's Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on theUCLA campus, strengthening the company's presence in the United States pet and animal health market. The two companies are now based at Magni...

2026-01-14 22:00 4749

Metabolon Appoints Celia Reyes as Vice President of Human Resources

Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace MORRISVILLE, N.C., Jan. 14, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science resea...

2026-01-14 22:00 2992

NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi ...

2026-01-14 21:55 7741

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc ., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system...

2026-01-14 21:03 3500

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ -- Lynx Analytics today announced  Lumen , a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from c...

2026-01-14 21:00 3355

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

HONG KONG, Jan. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy against a PD-1 inhibitor plus chemotherapy for th...

2026-01-14 11:54 4378

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ -- Rhythm Biosciences Ltd ('RHY ', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer (CRC) Risk Asses...

2026-01-14 11:40 2590

Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

* Celltrion outlines a blueprint for innovative drug development built on its antibody expertise * The company highlights its business strategy to scale U.S. manufacturing and R&D capabilities, strengthening its global supply chain, production and operations INCHEON, South Korea, Jan. 13, 202...

2026-01-14 09:18 4202

Teoxane to Launch First APAC Regional Academy in Bangkok

New hub strengthens Teoxane's commitment to scientific education and clinical partnerships across Asia-Pacific GENEVA, Jan. 14, 2026 /PRNewswire/ -- Teoxane opens its first APAC Regional Academy in Bangkok, Thailand this January, expanding its global medical-education n...

2026-01-14 08:15 2841

DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer diagnostics company Noul to certify their malaria diagnosis, blood cell morphology and cervical cancer testing solutions, under...

2026-01-14 08:00 4053

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical's production capabili...

2026-01-14 07:34 4309

Firstsource Acquires TeleMedik To Bolster Digital Offerings and Expand Presence in U.S. Healthcare Payer and Provider Markets

MUMBAI, India and DALLAS, Jan. 14, 2026 /PRNewswire/ -- Firstsource Solutions Limited  (NSE: FSL) (BSE: 532809), a leading global provider of business management services and an RP-Sanjiv Goenka Group company, today announced the acquisition ofTeleMedik

2026-01-14 03:19 3154

ArisGlobal Accelerates Growth and AI Adoption Following Strong 2025 Performance

More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum BOSTON, Jan. 14, 2026 /PRNewswire/ -- ArisGloba

2026-01-13 23:54 1747

Picarro Sets New Standard in Fenceline Monitoring for Hazardous Air Pollutants

Comprehensive Solution Delivers Real-Time, Defensible Measurements, Transforming Fenceline Monitoring into a Proactive Compliance and Risk Management Tool SANTA CLARA, Calif., Jan. 13, 2026 /PRNewswire/ -- Picarro, Inc., a global leader in emissions monitoring, analytics, and services, today annou...

2026-01-13 23:12 1176

Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Jan. 13, 2026 /PRNewswire/ -- Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral sclerosis (ALS). The initial dosing occurred at Second ...

2026-01-13 20:30 2972

Leo International Group Relocates Global Headquarters to Singapore Ahead of Its Centennial

Embodying a New Model of Inter-generational Enterprise Anchored in Healthcare, Finance and Education SINGAPORE, Jan. 13, 2026 /PRNewswire/ -- As Leo International Group approaches its centennial year in 2026, the Group is not merely commemorating a hundre...

2026-01-13 20:20 1663

Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ

SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2 CAR-T therapy, in patients with advanced gastric ...

2026-01-13 16:26 4352

ER-VIPE Simulation Game Builds Medical Students' Soft Skillsfor Real-World Emergency Care

BANGKOK, Jan. 13, 2026 /PRNewswire/ -- Chulalongkorn University 's Faculty of Medicine has developed ER-VIPE , a virtual emergency-room simulation platform designed to strengthen teamwork,...

2026-01-13 15:37 7056

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have r...

2026-01-13 11:07 3710
1 ... 13141516171819 ... 857

Week's Top Stories